[1]
Dmitriev, A.V.; Lagunin, A.A.; Karasev, D.A.; Rudik, A.V.; Pogodin, P.V.; Filimonov, D.A.; Poroikov, V.V. Prediction of drug-drug interactions related to inhibition or induction of drug-metabolizing enzymes. Curr. Top. Med. Chem., 2019, 19(5), 319-336.
[PMID: 30674264]
[PMID: 30674264]
[2]
Saxena, A.K.; Singh, A. Mycobacterial tuberculosis enzyme targets and their inhibitors. Curr. Top. Med. Chem, 2019, 19(5), 337-355.
[3]
Tratrat, C.; Haroun, M.; Xenikakis, I.; Liaras, K.; Tsolaki, E.; Eleftheriou, P.; Petrou, A.; Aldhubiab, B.; Attimarad, M.; Venugopala, K.N.; Harsha, S.;
Elsewedy, H.S.; Geronikaki, A. Soković, M. Design, synthesis, evaluation of antimicrobial activity and docking studies of new thiazole-based chalcones. Curr. Top. Med. Chem, 2019, 19(5), 356-375.
[4]
Jangra, S.; Purushothaman, G.; Juvale, K.; Ravi, S.; Menon, A.; Kirubakaran, S.; Thiruvenkatam, V. Synthesis and in vitro enzymatic studies of new
3-aryldiazenyl indoles as promising Helicobacter pylori IMPDH inhibitors. Curr. Top. Med. Chem., 2019, 19(5), 376-382.
[PMID: 30827248]
[PMID: 30827248]
[5]
Eleftheriou, P.; Therianou, E.; Lazari, D.; Dirnali, S.; Micha, A. Docking assisted prediction and biological evaluation of sideritis l. components with
PTP1B inhibitory action and probable anti-diabetic properties. Curr. Top. Med. Chem, 2019, 19(5), 383-392.
[PMID: 30806317]
[PMID: 30806317]
Current Topics in Medicinal Chemistry
Title:Trends in Enzyme Inhibition and Activation in Drug Design - Part II
Volume: 19 Issue: 5
Author(s): Athina Geronikaki
Affiliation:
Export Options
About this article
Cite this article as:
Geronikaki Athina , Trends in Enzyme Inhibition and Activation in Drug Design - Part II, Current Topics in Medicinal Chemistry 2019; 19 (5) . https://dx.doi.org/10.2174/156802661905190418152713
DOI https://dx.doi.org/10.2174/156802661905190418152713 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
28
4
1
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Discovery of JANUVIA <sup>TM</sup> (Sitagliptin), a Selective Dipeptidyl Peptidase IV Inhibitor for the Treatment of Type2 Diabetes.
Current Topics in Medicinal Chemistry Herb-Drug Interactions and Mechanistic and Clinical Considerations
Current Drug Metabolism Lipases in Medicine: An Overview
Mini-Reviews in Medicinal Chemistry The Role of Tregs in Cancer: Foxp3 as a Putative Target for Therapy
Current Signal Transduction Therapy Long Non-Coding RNAs As Epigenetic Regulators in Cancer
Current Pharmaceutical Design Status of Bi- and Multi-Nuclear Platinum Anticancer Drug Development
Anti-Cancer Agents in Medicinal Chemistry Using Cell Cultures for the Investigation of Treatments for Attention Deficit Hyperactivity Disorder: A Systematic Review
Current Neuropharmacology Chitosan Applications on Pharmaceutical Sciences: A Review
Drug Delivery Letters Radioiodinated Agents for Imaging Multidrug Resistant Tumors
Medicinal Chemistry Oral Nano-Delivery Systems for Colon Targeting Therapy
Pharmaceutical Nanotechnology Arsenic trioxide Alters the MicroRNA Expression Profile of U87 glioblastoma
Anti-Cancer Agents in Medicinal Chemistry MicroRNA Polymorphisms, MicroRNA Pharmacogenomics and Cancer Susceptibility
Current Pharmacogenomics and Personalized Medicine Non-Invasive Assessment of Non-Alcoholic Fatty Liver Disease: Ultrasound and Transient Elastography
Reviews on Recent Clinical Trials Human Carcinogenesis and Bracken Fern: A Review of the Evidence
Current Medicinal Chemistry Disease-Related Changes in TRPV1 Expression and Its Implications for Drug Development
Current Topics in Medicinal Chemistry A Systems Pharmacology Analysis of Major Chemotherapy Combination Regimens Used in Gastric Cancer Treatment: Predicting Potential New Protein Targets and Drugs
Current Cancer Drug Targets Enzymatic Processing of <i>Omega</i> 3 Long Chain Polyunsaturated Fatty Acid Oils
Current Nutrition & Food Science Valproic Acid As Anti-Cancer Drug
Current Pharmaceutical Design Omega-3 Polyunsaturated Fatty Acids Enhance Cisplatin Efficacy in Gastric Cancer Cells by Inducing Apoptosis via ADORA1
Anti-Cancer Agents in Medicinal Chemistry Non-Steroidal Anti-Inflammatory Drugs and Alzheimers Disease: The Epidemiological Evidence
CNS & Neurological Disorders - Drug Targets